SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Zhiyun Zheng, Bingyi Lin, Jing Zhang, Zhe Yang, Haiyang Xie, Lin Zhou, Min Zhang, Shusen Zheng, Absolute lymphocyte count recovery at 1 month after transplantation predicts favorable outcomes of patients with hepatocellular carcinoma, Journal of Gastroenterology and Hepatology, 2015, 30, 4
  2. 2
    Daisuke Hokuto, Masayuki Sho, Ichiro Yamato, Satoshi Yasuda, Shinsaku Obara, Takeo Nomi, Yoshiyuki Nakajima, Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma, European Journal of Cancer, 2015, 51, 2, 157

    CrossRef

  3. 3
    Hédia Boujedidi, Olivier Robert, Alexandre Bignon, Anne-Marie Cassard-Doulcier, Marie-Laure Renoud, Hélène Gary-Gouy, Patrice Hemon, Hugo Tharinger, Sophie Prévot, Françoise Bachelerie, Sylvie Naveau, Dominique Emilie, Karl Balabanian, Gabriel Perlemuter, CXCR4 dysfunction in non-alcoholic steatohepatitis in mice and patients, Clinical Science, 2015, 128, 4, 257

    CrossRef

  4. 4
    Yunching Chen, Rakesh R. Ramjiawan, Thomas Reiberger, Mei R. Ng, Tai Hato, Yuhui Huang, Hiroki Ochiai, Shuji Kitahara, Elizabeth C. Unan, Tejaswini P. Reddy, Christopher Fan, Peigen Huang, Nabeel Bardeesy, Andrew X. Zhu, Rakesh K. Jain, Dan G. Duda, CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice, Hepatology, 2015, 61, 5
  5. 5
    Lifeng Wang, Ying Sun, Zheng Zhang, Yiqiong Jia, Zhengsheng Zou, Jinbiao Ding, Yuanyuan Li, Xiangsheng Xu, Lei Jin, Tao Yang, Zhiwei Li, Yanling Sun, Ji-yuan Zhang, Sa Lv, Liming Chen, Baosen Li, M. Eric Gershwin, Fu-Sheng Wang, CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis, Hepatology, 2015, 61, 2
  6. 6
    Arun Kumar, Maria F Perdomo, Anu Kantele, Lea Hedman, Klaus Hedman, Rauli Franssila, Granzyme B mediated function of Parvovirus B19-specific CD4+ T cells, Clinical & Translational Immunology, 2015, 4, 7, e39

    CrossRef

  7. 7
    Kuo-Shyang Jeng, Chiung-Fang Chang, Wen-Juei Jeng, I-Shyan Sheen, Chi-Juei Jeng, Heterogeneity of hepatocellular carcinoma contributes to cancer progression, Critical Reviews in Oncology/Hematology, 2015, 94, 3, 337

    CrossRef

  8. 8
    J. D. Gibbins, L. R. Ancelet, R. Weinkove, B. J. Compton, G. F. Painter, T. R. Petersen, I. F. Hermans, An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment, Blood, 2014, 124, 19, 2953

    CrossRef

  9. 9
    Jun Zhou, Xiao-Zhen Xu, Yao-Ren Hu, Ai-Rong Hu, Cheng-Liang Zhu, Guo-Sheng Gao, Cryptotanshinone Induces Inhibition of Breast Tumor Growth by Cytotoxic CD4+ T Cells through the JAK2/STAT4/ Perforin Pathway, Asian Pacific Journal of Cancer Prevention, 2014, 15, 6, 2439

    CrossRef

  10. 10
    Kenji Yorita, Akinobu Ohno, Hiroaki Kataoka, Emerging histopathological prognostic biomarkers in hepatocellular carcinomas, Personalized Medicine Universe, 2014, 3, 15

    CrossRef

  11. 11
    E. Lukesova, J. Boucek, E. Rotnaglova, M. Salakova, E. Koslabova, M. Grega, T. Eckschlager, B. Rihova, B. Prochazka, J. Klozar, R. Tachezy, High Level of Tregs Is a Positive Prognostic Marker in Patients with HPV-Positive Oral and Oropharyngeal Squamous Cell Carcinomas, BioMed Research International, 2014, 2014, 1

    CrossRef

  12. 12
    Jose Villacorta Hidalgo, Peter Bronsert, Marzenna Orlowska-Volk, Liliana B. Díaz, Elmar Stickeler, Martin Werner, Annette Schmitt-Graeff, Gian Kayser, Miroslav Malkovsky, Paul Fisch, Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas, Frontiers in Immunology, 2014, 5,

    CrossRef

  13. 13
    Jeong-Ju Yoo, Jeong-Hoon Lee, Kyung Boon Lee, Jae Moon Koh, Minjong Lee, Young Hoon Choi, Jung-Hwan Yoon, Pathologically Confirmed Spontaneous Partial Regression of Hepatocellular Carcinoma, Korean Journal of Medicine, 2014, 86, 2, 198

    CrossRef

  14. 14
    Roniel Cabrera, Gyongyi Szabo, Another armed CD4+ T cell ready to battle hepatocellular carcinoma, Hepatology, 2013, 58, 1
  15. 15
    Hilde Cheroutre, Mohammad Mushtaq Husain, CD4 CTL: Living up to the challenge, Seminars in Immunology, 2013, 25, 4, 273

    CrossRef